Cardiovascular · PANCE / PANRE

Deep Vein Thrombosis (DVT)

Thrombus in the deep venous system, most often lower extremity — risk-stratify with Wells, confirm with duplex US, treat with anticoagulation.

Also known as: DVT, deep vein thrombosis, venous thromboembolism, VTE, lower extremity thrombosis

Overview

Formation of thrombus within the deep venous system, most commonly involving lower extremity veins (popliteal, femoral, iliac). Proximal DVT (popliteal or above) carries the highest risk of pulmonary embolism; distal (calf) DVT is generally lower risk.

Epidemiology

Annual incidence of venous thromboembolism ~1-2 per 1000. Together with PE, VTE is the third most common cardiovascular cause of death. Up to half are provoked by identifiable risk factors; the remainder unprovoked.

Try two board-style Deep Vein Thrombosis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1CardiovascularMedium
A 55-year-old man presents with unilateral leg swelling 5 days after a long flight. His two-tier Wells deep vein thrombosis (DVT) score is 1 (DVT 'unlikely'). High-sensitivity D-dimer returns at 280 ng/mL (cutoff <500). What is the most appropriate next step?
  • ACT venography of the lower extremity
  • BNo further imaging or anticoagulation at this time
  • CCompression ultrasound of the lower extremity
  • DEmpiric therapeutic anticoagulation
Reveal answer & full explanation
Correct answer: B — No further imaging or anticoagulation at this time
  • ACT venography of the lower extremity
  • BNo further imaging or anticoagulation at this time
  • CCompression ultrasound of the lower extremity
  • DEmpiric therapeutic anticoagulation

Why No further imaging or anticoagulation at this time is correct

  • For a non-high-probability Wells deep vein thrombosis (DVT) score, a negative high-sensitivity D-dimer (<500 ng/mL) effectively excludes DVT with high negative predictive value
  • No further imaging is needed when Wells score is 'unlikely' and D-dimer is negative

Why the others are wrong

  • CT venography of the lower extremity — is rarely first-line in DVT evaluation
  • Compression ultrasound of the lower extremity — would be the next step only if Wells score were 'likely' (>=2 in the two-tier model), in which case one proceeds directly to compression ultrasound regardless of D-dimer
  • Empiric therapeutic anticoagulation — is not justified without imaging confirmation in low/moderate probability patients with a negative D-dimer
Question 2CardiovascularEasy
A 34-year-old woman is 2 weeks postpartum after cesarean delivery and now has unilateral calf swelling. Her recovery has been slow and she has spent most days resting at home. Which of the following is the strongest risk factor for this condition?
  • AMaternal age older than 30 years
  • BPostpartum iron-deficiency anemia
  • CRecent pregnancy with immobility
  • DEpidural anesthesia at delivery
Reveal answer & full explanation
Correct answer: C — Recent pregnancy with immobility
  • AMaternal age older than 30 years
  • BPostpartum iron-deficiency anemia
  • CRecent pregnancy with immobility
  • DEpidural anesthesia at delivery

Why Recent pregnancy with immobility is correct

  • Unilateral calf swelling postpartum is suspicious for deep vein thrombosis, and the strongest contributor is the postpartum/cesarean state combined with immobility.
  • These exposures hit all three arms of Virchow's triad: hypercoagulability of pregnancy, stasis from sedentary recovery, and endothelial injury from surgery.
  • VTE risk is highest in the first 6 weeks after delivery, so this clustering is decisive.

Why the others are wrong

  • Maternal age older than 30 years — Advancing maternal age adds only a modest increment to peripartum VTE risk and is nowhere near the effect of the postpartum hypercoagulable state after cesarean.
  • Postpartum iron-deficiency anemia — Anemia after cesarean delivery causes fatigue and pallor, but it is not one of the recognized drivers of peripartum venous thromboembolism the way recent surgery and immobility are.
  • Epidural anesthesia at delivery — Neuraxial anesthesia matters for spinal hematoma risk when anticoagulation is started, but it does not itself promote deep vein thrombosis.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Deep Vein Thrombosis (DVT) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Virchow triad: venous stasis, endothelial injury, hypercoagulability
  • Surgery (especially orthopedic — hip, knee, pelvic; total joint replacement carries highest risk)
  • Trauma, immobilization (hospitalization, casting, long-haul travel)
  • Active malignancy (especially pancreatic, gastric, ovarian, brain — Trousseau syndrome)
  • Pregnancy and 6-week postpartum period
  • Oral contraceptives, hormone replacement therapy, tamoxifen
  • Inherited thrombophilia: Factor V Leiden, prothrombin G20210A, protein C/S/antithrombin deficiency
  • Antiphospholipid antibody syndrome
  • Obesity, age >60, smoking
  • Prior VTE (strongest single risk factor for recurrence)
  • Central venous catheter, indwelling hardware

Pathophysiology

Stasis in venous valve cusps combined with hypercoagulable state initiates thrombus formation. The thrombus may extend proximally or embolize to the pulmonary circulation. Chronic venous outflow obstruction and valvular damage lead to post-thrombotic syndrome.

Clinical presentation

Symptoms

  • Unilateral leg swelling and pain (most common)
  • Calf or thigh discomfort, often worse with walking
  • Warmth, erythema
  • Asymptomatic in many cases — first manifestation may be pulmonary embolism
  • Phlegmasia cerulea dolens (rare, limb-threatening): severe swelling, cyanosis, pain from massive iliofemoral thrombus

Signs / physical exam

  • Unilateral leg swelling >3 cm calf circumference difference (measured 10 cm below tibial tuberosity)
  • Pitting edema, palpable cord
  • Erythema, warmth
  • Homan sign (calf pain with dorsiflexion) — historical, low sensitivity/specificity
  • Tachycardia, hypoxia if concurrent PE

Differential diagnosis

  • Cellulitis — Erythema with sharp borders, fever, leukocytosis; warmth without palpable cord; negative duplex
  • Ruptured Baker cyst — Sudden calf pain with cyst rupture; ultrasound shows fluid tracking down calf without venous thrombus
  • Muscle strain or hematoma — Trauma history, localized tenderness; negative duplex
  • Chronic venous insufficiency / superficial thrombophlebitis — Palpable cord along superficial vein; tender erythematous track; treated with NSAIDs ± anticoagulation if extensive
  • Lymphedema — Chronic non-pitting edema with skin changes; bilateral or asymmetric without acute pain
  • Compartment syndrome — Pain out of proportion, paresthesia, post-trauma or post-exercise; emergent surgical consult
  • Heart failure — Bilateral pitting edema with dyspnea, elevated JVP, pulmonary congestion

Diagnostic workup

Diagnostic criteria

Wells DVT score: each +1 for active cancer, paralysis/immobilization, recent surgery, localized tenderness along deep veins, entire leg swelling, calf >3 cm difference, pitting edema, collateral superficial veins, prior DVT; subtract 2 if alternative diagnosis as likely. Score ≥2 = likely; <2 = unlikely. Unlikely + negative D-dimer rules out; likely or positive D-dimer warrants duplex.

Labs

  • D-dimer — sensitive but nonspecific; useful in low-pretest-probability patients to exclude DVT
  • CBC, BMP, coagulation studies, hepatic function (drug dosing)
  • Pregnancy test in women of childbearing age
  • Selective thrombophilia workup (Factor V Leiden, prothrombin G20210A, protein C/S, antithrombin, antiphospholipid antibodies) — in young unprovoked DVT, recurrent VTE, or strong family history; defer testing until off anticoagulation when possible
  • Age-appropriate cancer screening for unprovoked VTE — no aggressive occult malignancy workup unless symptoms or signs

Imaging

  • Compression duplex ultrasound — first-line; sensitivity and specificity >95% for proximal DVT
  • CT or MR venography for proximal pelvic veins or IVC when duplex limited
  • Echocardiography and CTPA if PE suspected concurrently
  • Wells criteria for clinical pretest probability — drives D-dimer vs imaging decision

Diagnostic algorithm

flowchart TD
  A[Suspected DVT] --> B[Wells DVT score]
  B --> C{Score}
  C -->|Unlikely <2| D[D-dimer]
  D --> E{D-dimer<br/>elevated?}
  E -->|No| F[DVT excluded]
  E -->|Yes| G[Compression duplex US]
  C -->|Likely ≥2| G
  G --> H{Thrombus<br/>identified?}
  H -->|No| I[Consider alternate dx<br/>or repeat US in 5-7 days<br/>if high suspicion]
  H -->|Yes| J[Anticoagulate: DOAC preferred<br/>LMWH for pregnancy/cancer<br/>Warfarin if specific indication]
  J --> K{Provoked vs<br/>unprovoked?}
  K -->|Provoked| L[3 months therapy]
  K -->|Unprovoked / recurrent /<br/>persistent risk| M[Consider indefinite therapy<br/>based on bleeding risk]
Diagnostic and treatment algorithm for suspected lower extremity DVT.

Treatment

First-line

  • Anticoagulation — direct oral anticoagulants (DOACs) preferred for most acute VTE in absence of contraindications:
  • • Apixaban 10 mg PO BID × 7 days then 5 mg BID
  • • Rivaroxaban 15 mg PO BID × 21 days then 20 mg daily with food
  • • Edoxaban — requires 5-10 day bridge with parenteral anticoagulation first
  • • Dabigatran — requires 5-10 day bridge with parenteral anticoagulation first
  • Low-molecular-weight heparin (enoxaparin 1 mg/kg SC q12h) — preferred in pregnancy, active cancer (especially GI malignancy where DOACs have higher bleeding), severe renal impairment may use IV unfractionated heparin
  • Warfarin with parenteral bridging (target INR 2-3) — for patients on warfarin already, mechanical heart valves, certain APS, or DOAC intolerance
  • Duration: 3 months minimum for provoked DVT; indefinite for unprovoked proximal DVT or PE with low bleeding risk, recurrent VTE, or persistent risk factor

Second-line / adjunct

  • IVC filter — only for acute VTE with absolute contraindication to anticoagulation, or recurrent VTE despite therapeutic anticoagulation; retrievable filters preferred and should be removed when anticoagulation can resume
  • Catheter-directed thrombolysis or thrombectomy — for limb-threatening iliofemoral DVT (phlegmasia) or selected young patients with extensive proximal DVT to reduce post-thrombotic syndrome
  • Compression stockings (20-30 mmHg) for symptomatic relief; routine use no longer recommended solely to prevent post-thrombotic syndrome (SOX trial)
  • Address modifiable risk factors: stop estrogen-containing contraceptives, treat malignancy, weight management
  • Hospitalize if extensive DVT, suspected concurrent PE, hemodynamic compromise, high bleeding risk, or limited social support

Complications

  • Pulmonary embolism (the dreaded complication; can be fatal)
  • Post-thrombotic syndrome — chronic pain, edema, hyperpigmentation, venous ulceration
  • Chronic thromboembolic pulmonary hypertension
  • Recurrent VTE
  • Anticoagulation-related bleeding (intracranial, GI)
  • Phlegmasia cerulea dolens with limb loss

PANCE pearls

  • Wells score with negative D-dimer reliably rules out DVT in low-risk outpatients — saves imaging.
  • DOACs are first-line for most VTE; LMWH still preferred in pregnancy and many GI malignancies.
  • Unprovoked proximal DVT or PE → consider indefinite anticoagulation given high recurrence risk.
  • Stop estrogen-containing contraceptives in any patient diagnosed with VTE on hormonal therapy.
  • IVC filters are reserved for those who CANNOT be anticoagulated — they do not replace anticoagulation when it can be given.

References

  • CHEST 2021 VTE — Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report (Stevens et al., Chest 2021)
  • ASH 2020 VTE — American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism (Ortel et al., Blood Adv 2020)
  • AMPLIFY — Oral Apixaban for the Treatment of Acute Venous Thromboembolism (Agnelli et al., NEJM 2013)
  • EINSTEIN-DVT — Oral Rivaroxaban for Symptomatic Venous Thromboembolism (EINSTEIN Investigators, NEJM 2010)
  • SOX Trial — Compression Stockings to Prevent Post-Thrombotic Syndrome (Kahn et al., Lancet 2014)

Practice Cardiovascular questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.